Evidence-based respiratory medicine / / edited by Peter Gibson ... [et al.]
| Evidence-based respiratory medicine / / edited by Peter Gibson ... [et al.] |
| Pubbl/distr/stampa | London, : BMJ, 2005 |
| Descrizione fisica | 1 online resource (642 p.) |
| Disciplina | 616.20046 |
| Altri autori (Persone) | GibsonPeter G |
| Collana | Evidence-Based Medicine |
| Soggetto topico |
Respiratory organs - Diseases
Evidence-based medicine |
| ISBN |
9786610742974
9781280742972 1280742976 9780470790502 0470790504 9780470987377 0470987375 9781405172370 1405172371 |
| Classificazione | 44.84 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Evidence-based Respiratory Medicine; Contents; Contributors; Acknowledgement to Cochrane Library; 1. Practising evidence-based respiratory medicine; 1.1 Introduction; 1.2 Diagnostic strategies; 1.2.1 Presenting symptoms; 1.2.2 Lung function testing; 1.2.3 Chest radiographic and computerized tomography patterns; 1.2.4 Diagnostic strategies in pulmonary embolism: an evidence-based approach; 1.2.5 Screening for lung cancer; 1.3 Therapeutics: general issues; 1.3.1 Adherence and self-management; 1.3.2 Corticosteroid-induced osteoporosis; 1.3.3 Helping people to stop smoking; 2. Asthma
2.1 Acute exacerbations2.2 Chronic therapy: B-agonists,short-acting,long-acting B2-agonists; 2.3 Inhaled corticosteroids in the treatment of asthma; 2.4 Anti-leukotrienes; 2.5 Asthma education; 2.6 Non-pharmacological and complementary interventions to manage asthma; 2.7 Difficult asthma; 2.8 Novel therapies in asthma: long-acting B2 -agonists/inhaled corticosteroids; 3. Chronic obstructive pulmonary disease; 3.1 Chronic obstructive pulmonary disease -acute exacerbations; 3.2 Anticholinergic bronchodilators in chronic obstructive pulmonary disease therapy 3.3 Inhaled corticosteroids in chronic obstructive pulmonary disease3.4 Combination of inhaled corticosteroids and long-acting B2 -agonists in chronic obstructive pulmonary disease; 3.5 Systemic corticosteroids in stable chronic obstructive pulmonary disease; 3.6 Lung volume reduction; 4. Infection; 4.1 Bronchitis and sinusitis; 4.2 Community-acquired pneumonia; 4.3 Pulmonary tuberculosis; 4.4 Influenza: vaccination and treatment; 4.5 Bronchiectasis; 4.6 Adult cystic fibrosis; 4.7 Antibiotics in chronic obstructive pulmonary disease, bronchiectasis and cystic fibrosis 5. Respiratory failure/sleep-disordered breathing5.1 Respiratory rehabilitation; 5.2 Non-invasive ventilation in acute respiratory failure; 5.3 Non-invasive positive pressure ventilation in stable patients with chronic obstructive pulmonary disease. What is the evidence?; 5.4 The treatment of the obstructive sleep apnoea-hypopnoea syndrome; 5.5 Long-term oxygen therapy for chronic respiratory failure in chronic obstructive pulmonary disease; 6. Diffuse lung disease/pleural disease/thromboembolism; 6.1 Diffuse lung disease; 6.1.1 The treatment of cryptogenic fibrosing alveolitis 6.1.2 Evidence-based approach to the treatment of sarcoidosis6.1.3 Hypersensitivity pneumonitis; 6.2 Pleural disease; 6.3 Therapy of pulmonary thromboembolism: an evidence-based approach; 6.4 Pulmonary hypertension; Index |
| Record Nr. | UNINA-9911020101703321 |
| London, : BMJ, 2005 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Noninvasive Mechanical Ventilation in High Risk Infections, Mass Casualty and Pandemics / / edited by Antonio M. Esquinas
| Noninvasive Mechanical Ventilation in High Risk Infections, Mass Casualty and Pandemics / / edited by Antonio M. Esquinas |
| Autore | Esquinas Antonio M |
| Edizione | [2nd ed. 2023.] |
| Pubbl/distr/stampa | Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (473 pages) |
| Disciplina | 616.20046 |
| Soggetto topico |
Critical care medicine
Respiratory organs - Diseases Anesthesiology Emergency medicine Intensive Care Medicine Pneumology Emergency Medicine |
| ISBN | 3-031-29673-7 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | PART I. NIV and ARF: Transmission, Physiopathology, Equipment and Technology -- Mechanical ventilation and history in pandemics -- Pre-hospital ARF -- Hospital Organizations -- Transmission of severe acute respiratory syndrome during intubation and mechanical ventilation -- Rationale of Acute Respiratory Failure treatments in high risk infections -- Rationale of ARF approach in mass causalities -- Pathophysiology-High risk infections -- Nasal high flow oxygen equipment -- CPAP systems -- What Interface? -- NIV via different face masks / Helmets -- Humidification and aerosol therapy -- Models to assess air and particle dispersion -- Droplet dispersion during noninvasive oxygen therapy, nebulizer treatment and chest physic -- Part II. Summary of Clinical Experience, Guidelines, Protocols and Outcome -- NIV in Severe Acute Respiratory Syndrome (SARS) -- NIV in avian flu -- NIV in H1N1 -- NIV support in coronavirus (COVID-19) -- NIV in Acute Immunodeficiency Diseases -- NIV in Legionella pneumophila -- NIV in Tuberculosis -- NIV transplants and immunocompromised -- Nasal high flow in high risk pediatric neonatology -- Nasal high flow in high risk pediatric infections -- Guidelines and protocol -- Prognostic factors in high risk infections -- Part III. Strategies to Control Infections in Hospitals -- Negative pressure rooms or well ventilated rooms -- Bacterial and viral filters to the expiratory circuit -- Personal protection equipment for health care workers -- Part IV. Failure Noninvasive Ventilator Approach -- Failure nasal high flow oxygen in high risk infections -- NIV-Reports of national surveys in epidemic- and pandemic -- Failure of noninvasive ventilator approach in high risk infections. Key determinants -- Endotracheal intubation in high risk infections -- Airway management in failure noninvasive ventilation in high risk infections -- Radiology findings in acute respiratory failure in common high risk infections -- Part V. Procedures in NIV Approach. Guidelines, Recommendations and itsEffectiveness in ARF Treatment -- Bronchoscopy and non- invasive ventilation in high risk infections -- Summary of effectiveness of NIV in the treatment of acute respiratory failure -- Part VI. NIV in the Treatment of ARF: Biological and Non-biological Mass Causalities -- Hospital Bioterrorism Response. Programs -- Influenza and other airborne infections -- Massive intoxications -- NIV in Politrauma -- Burn -- Chemical disasters -- PART VII. Outcome, Ethics, Palliative and Do Not Endotracheal Intubation -- Health Organizations guidelines -- Outcome noninvasive ventilator approach in high risk infections -- Ethical dilemmas and do not endotracheal intubation orders -- PART VIII. Future Research About NIV Approach in High Risk Infections, Mass Casualties and Pandemics -- Lessons for lasts pandemics and for the future. |
| Record Nr. | UNINA-9910734850703321 |
Esquinas Antonio M
|
||
| Cham : , : Springer International Publishing : , : Imprint : Springer, , 2023 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Tracheal Intubation / / edited by Rıza Hakan Erbay
| Tracheal Intubation / / edited by Rıza Hakan Erbay |
| Pubbl/distr/stampa | Croatia : , : IntechOpen, , 2018 |
| Descrizione fisica | 1 online resource (136 pages) : illustrations |
| Disciplina | 616.20046 |
| Soggetto topico | Intubation, Intratracheal |
| ISBN |
1-83881-502-3
1-78923-489-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910317802203321 |
| Croatia : , : IntechOpen, , 2018 | ||
| Lo trovi qui: Univ. Federico II | ||
| ||